109.1
Checked 160-ranking
指數排名
排名 · 160 分制
| Action | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| #1 US.CSGP CoStar Group | 109.1 Checked 160-ranking | 74.1 /110 | 35 /50 | -1.41% | 42.5% | 13.8% | elevated | Real Estate | 1D +7.49% Close $33.73 | $196.26M 5,818,500 shares | Improving | View score | |
| #2 US.MRNA Moderna | 108.7 Checked 160-ranking | 61.7 /110 | 47 /50 | -0.98% | 38.8% | 16.3% | elevated | Health Care | 1D +176.97% Close $174.38 | $34.75B 199,252,300 shares | Improving | View score | |
| #3 US.MRK Merck & Co. | 107.7 Checked 160-ranking | 65.7 /110 | 42 /50 | -0.87% | 40% | 10% | medium | Health Care | 1D +12.60% Close $152.20 | $4.99B 32,776,300 shares | Improving | View score | |
| #4 US.TGT Target Corporation | 105.3 Checked 160-ranking | 71.3 /110 | 34 /50 | -0.19% | 47.5% | 8.8% | medium | Consumer Staples | 1D +4.28% Close $159.00 | $1.51B 9,467,500 shares | Improving | View score | |
| #5 US.A Agilent Technologies | 104.9 Checked 160-ranking | 71.9 /110 | 33 /50 | -0.84% | 38.8% | 7.5% | medium | Health Care | 1D +4.70% Close $155.41 | $467.19M 3,006,200 shares | Healthy | View score | |
| #6 US.EL Estée Lauder Companies (The) | 103.4 Checked 160-ranking | 59.4 /110 | 44 /50 | -1.39% | 35% | 10% | medium | Consumer Staples | 1D +16.30% Close $98.01 | $1.34B 13,700,900 shares | Strong | View score | |
| #7 US.MCO Moody's Corporation | 99.2 Checked 160-ranking | 74.2 /110 | 25 /50 | -0.73% | 40% | 10% | low | Financials | 1D +2.31% Close $497.03 | $475.51M 956,700 shares | Improving | View score | |
| #8 US.JKHY Jack Henry & Associates | 98.1 Checked 160-ranking | 59.1 /110 | 39 /50 | -1.09% | 41.3% | 7.5% | medium | Financials | 1D +6.49% Close $163.06 | $317.62M 1,947,900 shares | Improving | View score | |
| #9 US.CPRT Copart | 97.2 Checked 160-ranking | 62.2 /110 | 35 /50 | -1.46% | 32.5% | 3.8% | medium | Industrials | 1D +7.43% Close $33.85 | $464.74M 13,729,500 shares | Improving | View score | |
| #10 US.INTU Intuit | 96.7 Checked 160-ranking | 66.7 /110 | 30 /50 | -0.16% | 47.5% | 21.3% | elevated | Information Technology | 1D +3.44% Close $362.47 | $1.46B 4,018,300 shares | Healthy | View score | |
| #11 US.PFE Pfizer | 95.4 Checked 160-ranking | 58.4 /110 | 37 /50 | -0.47% | 42.5% | 7.5% | medium | Health Care | 1D +3.63% Close $28.24 | $1.69B 59,804,200 shares | Improving | View score | |
| #12 US.CRM Salesforce | 94.7 Checked 160-ranking | 61.7 /110 | 33 /50 | -0.59% | 43.8% | 17.5% | medium | Information Technology | 1D +5.07% Close $206.09 | $3.68B 17,843,600 shares | Improving | View score | |
| #13 US.BIIB Biogen | 94.3 Checked 160-ranking | 65.3 /110 | 29 /50 | -0.89% | 37.5% | 8.8% | medium | Health Care | 1D +4.24% Close $221.56 | $196.48M 886,800 shares | Improving | View score | |
| #14 US.AXON Axon Enterprise | 93.1 Checked 160-ranking | 67.1 /110 | 26 /50 | -0.84% | 41.3% | 6.3% | elevated | Industrials | 1D +4.17% Close $645.72 | $503.53M 779,800 shares | Healthy | View score | |
| #15 US.RVTY Revvity | 92.5 Checked 160-ranking | 68.5 /110 | 24 /50 | -0.37% | 38.8% | 8.8% | medium | Health Care | 1D +5.01% Close $119.45 | $205.19M 1,717,800 shares | Watch | View score | |
| #16 US.LLY Lilly (Eli) | 92.1 Checked 160-ranking | 66.1 /110 | 26 /50 | -0.81% | 37.5% | 8.8% | medium | Health Care | 1D +4.46% Close $1280.34 | $5.82B 4,541,800 shares | Healthy | View score | |
| #17 US.CAG Conagra Brands | 91.7 Checked 160-ranking | 60.7 /110 | 31 /50 | -0.86% | 43.8% | 8.8% | medium | Consumer Staples | 1D +4.51% Close $16.22 | $215.83M 13,306,700 shares | Improving | View score | |
| #18 US.EFX Equifax | 91.7 Checked 160-ranking | 59.7 /110 | 32 /50 | -0.84% | 37.5% | 7.5% | medium | Industrials | 1D +5.64% Close $192.10 | $303.48M 1,579,800 shares | Healthy | View score | |
| #19 US.GILD Gilead Sciences | 91.7 Checked 160-ranking | 66.7 /110 | 25 /50 | -1.01% | 37.5% | 7.5% | medium | Health Care | 1D +2.90% Close $147.60 | $994.62M 6,738,600 shares | Improving | View score | |
| #20 US.DHR Danaher Corporation | 91.3 Checked 160-ranking | 65.3 /110 | 26 /50 | -0.81% | 38.8% | 8.8% | medium | Health Care | 1D +5.97% Close $211.50 | $1.11B 5,253,000 shares | Healthy | View score | |
| #21 US.TMO Thermo Fisher Scientific | 90.5 Checked 160-ranking | 66.5 /110 | 24 /50 | -1.01% | 36.3% | 8.8% | medium | Health Care | 1D +4.16% Close $613.54 | $1.54B 2,507,200 shares | Watch | View score | |
| #22 US.APA APA Corporation | 90.4 Checked 160-ranking | 62.4 /110 | 28 /50 | -0.79% | 43.8% | 16.3% | elevated | Energy | 1D +2.55% Close $43.45 | $379.83M 8,741,800 shares | Watch | View score | |
| #23 US.LDOS Leidos | 90.4 Checked 160-ranking | 70.4 /110 | 20 /50 | -0.66% | 38.8% | 7.5% | elevated | Industrials | 1D +1.97% Close $146.31 | $171.37M 1,171,300 shares | Watch | View score | |
| #24 US.NFLX Netflix | 90.3 Checked 160-ranking | 61.3 /110 | 29 /50 | -0.95% | 38.8% | 12.5% | medium | Communication Services | 1D +3.15% Close $80.22 | $2.52B 31,461,800 shares | Improving | View score | |
| #25 US.VRTX Vertex Pharmaceuticals | 90.3 Checked 160-ranking | 63.3 /110 | 27 /50 | -0.81% | 38.8% | 7.5% | medium | Health Care | 1D +4.52% Close $552.06 | $793.48M 1,437,300 shares | Watch | View score | |
| #26 US.AMGN Amgen | 89.9 Checked 160-ranking | 64.9 /110 | 25 /50 | -0.85% | 38.8% | 7.5% | medium | Health Care | 1D +4.02% Close $442.36 | $1.13B 2,544,000 shares | Healthy | View score | |
| #27 US.BDX Becton Dickinson | 89.8 Checked 160-ranking | 68.8 /110 | 21 /50 | -0.77% | 36.3% | 10% | medium | Health Care | 1D +3.78% Close $187.60 | $406.06M 2,164,500 shares | Healthy | View score | |
| #28 US.NEM Newmont | 89.8 Checked 160-ranking | 62.8 /110 | 27 /50 | -0.25% | 45% | 15% | elevated | Materials | 1D +7.85% Close $125.08 | $1.13B 9,071,900 shares | Healthy | View score | |
| #29 US.RMD ResMed | 89.8 Checked 160-ranking | 68.8 /110 | 21 /50 | -0.85% | 36.3% | 10% | medium | Health Care | 1D +4.85% Close $230.65 | $279.04M 1,209,800 shares | Watch | View score | |
| #30 US.CBRE CBRE Group | 89.3 Checked 160-ranking | 63.3 /110 | 26 /50 | -0.08% | 48.8% | 1.3% | medium | Real Estate | 1D +5.28% Close $155.07 | $237.16M 1,529,400 shares | Healthy | View score |
109.1
Checked 160-ranking
108.7
Checked 160-ranking
107.7
Checked 160-ranking
105.3
Checked 160-ranking
104.9
Checked 160-ranking
103.4
Checked 160-ranking
99.2
Checked 160-ranking
98.1
Checked 160-ranking
97.2
Checked 160-ranking
96.7
Checked 160-ranking
95.4
Checked 160-ranking
94.7
Checked 160-ranking
Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.